Kristina Torfgaard
CEO
Replay available
IRLAB Therapeutics AB (publ) (IRLAB_A) Q4 2024 Earnings Call
IRLAB Therapeutics AB (publ) (STO: IRLAB_A) Q4 2024 earnings conference call, held 2025-02-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Nicholas Waters
Executive Vice President, R&D
Viktor Sivic
CFO
Aaron Atker
Equity Analyst, Edison
Fredrik Thor
Equity Analyst, Redeye
Alexander Kramer
Equity Analyst, ABG Sundal Collier
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Irlab Therapeutics Ab Class A.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.736 Welcome to the quarterly presentation of the fourth quarter and the year-end results 00:00:04.736 -- 00:00:08.259 by research company iLab Therapeutics. 00:00:08.259 -- 00:00:13.384 Presenting today is CEO Kristina Torfgaard, Executive Vice President 00:00:13.384 -- 00:00:18.990 R&D Nicholas Waters and CFO Viktor Sivic. After the presentation 00:00:18.990 -- 00:00:24.115 we will be given a Q&A with participating equity analysts and viewers can ask their 00:00:24.115 -- 00:00:29.782 questions in the live chat. Hello and welcome Kristina Torfgaard. 00:00:29.782 -- 00:00:31.624 Hello, good morning. 00:00:31.624 -- 00:00:37.230 Please go ahead with your presentation and I will be back for the Q&A. 00:00:37.230 -- 00:00:43.875 Thanks. So can we have the first slide and the next one, please? 00:00:43.897 -- 00:00:46.520 So today's agenda, 00:00:46.520 -- 00:00:52.026 I will introduce and take you through the news of this period 00:00:52.026 -- 00:00:57.152 and beyond that. That will be followed up by the R&D 00:00:57.152 -- 00:01:02.159 update from Nicholas Waters, EVP, 00:01:02.159 -- 00:01:04.001 head of R&D. 00:01:04.001 -- 00:01:09.008 And then Victor Sieverts will continue with the financials. 00:01:09.008 -- 00:01:14.135 And I will have some concluding words and also inform you a little bit 00:01:14.135 -- 00:01:17.299 about the future. So 00:01:17.299 -- 00:01:19.879 the next slide, please. 00:01:20.272 -- 00:01:25.857 So I would just like to remind you that IOLAB, we are developing new, 00:01:25.857 -- 00:01:31.002 innovative and better medicines for treating Parkinson's disease for all 00:01:31.002 -- 00:01:36.587 the different stages. On this slide, you can see the core and the main 00:01:36.587 -- 00:01:42.072 symptoms that th...